Synopsys, Inc.
Bear Case (25th pct.)
-82.1% vs price
Base Case (Median)
-72.7% vs price
Bull Case (75th pct.)
-68.4% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1.25 | -99.7% | High (40%) |
| PE Comparable | $109.82 | -75.9% | Medium (25%) |
| Growth Trajectory DCF | $124.60 | -72.7% | Medium (20%) |
| Graham Number | $132.02 | -71.1% | Low (10%) |
| EV/EBITDA | $156.10 | -65.8% | Medium (20%) |
| EV/FCF | $334.12 | -26.8% | Medium (20%) |
| Earnings Power Value | $53.76 | -88.2% | Medium (50%) |
Based on 7 out of 8 methods, SNPS appears overvalued at the current price of $456.29. The base case fair value of $124.60 implies 72.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.